Global Leading Market Research Publisher QYResearch announces the release of its latest report “Nutraceutical Gummies – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Nutraceutical Gummies market, including market size, share, demand, industry development status, and forecasts for the next few years.
For consumer health brand managers, nutraceutical manufacturing directors, and wellness industry investors, the traditional pill and capsule format faces a growing adherence problem. Up to 40-50% of consumers discontinue daily vitamin regimens within six months, citing pill fatigue, swallowing difficulty, and unpleasant aftertaste. Nutraceutical Gummies address this adherence gap directly: they are chewable, palatable, and increasingly formulated to contain various vitamins, DHA, Omega-3, probiotics, minerals, and other functional actives. The global market for Nutraceutical Gummies was estimated to be worth USD 1,549 million in 2024 and is forecast to reach USD 2,688 million by 2031, growing at a CAGR of 8.2% from 2025 to 2031. This double-digit growth is driven by three structural forces: the shift from tablets to gummies across all age demographics (children, adults, and seniors), innovation in starch-free manufacturing enabling heat-sensitive active ingredients (probiotics, Omega-3), and expanding applications beyond basic vitamins into specialty segments such as sleep support, immunity, and beauty-from-within.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4736843/nutraceutical-gummies
Product Definition: Beyond the Candy Aesthetic
Nutraceutical Gummies are one of the fastest-growing segments in the broader nutraceutical industry across Europe, North America, and Asia. Unlike conventional confectionery gummies, nutraceutical versions are formulated to deliver precise dosages of active ingredients while maintaining acceptable taste, texture, and stability over shelf life (typically 18–24 months).
Core Active Ingredient Categories:
- Vitamins and Minerals: Multivitamin formulations (A, B-complex, C, D, E, K), single-ingredient vitamin C or D3 gummies, and mineral-fortified gummies (zinc, calcium, magnesium). This segment represented approximately 63.04% of global market size, making it the dominant application area.
- DHA and Omega-3 Gummies: Addressing the growing demand for cognitive health and prenatal nutrition. Formulation challenge: preventing fishy taste and oxidation of polyunsaturated fatty acids.
- Probiotics Gummies: Supporting digestive and immune health. Manufacturing challenge: maintaining probiotic viability through the gummy production process (heat and shear sensitivity) and shelf life (moisture control).
- Plant Extract Gummies: Botanical ingredients including elderberry (immunity), turmeric (anti-inflammatory), ashwagandha (stress), and melatonin (sleep support).
- Other Gummies: Collagen (beauty-from-within), biotin (hair/skin/nails), fiber, and CBD (in markets where permitted).
Palatability and Adherence Advantage: The gummy format reduces perceived “medication burden” compared to pills or capsules. Consumer research (2025) indicates that 70% of adults prefer gummy vitamins over tablets when given a choice, and 80% of parents report higher child compliance with gummy formats versus chewable tablets or liquids. This preference translates directly into higher brand loyalty and repeat purchase rates.
Production Technology: Starch Process vs. Starch-Free Process
The process of producing functional gummies using starch molds is a traditional process that has been refined over decades. Key characteristics:
Starch Mold Process (Traditional):
- Method: A starch tray is imprinted with gummy-shaped cavities using a metal die. The gummy slurry is deposited into cavities, allowed to set (gel), then demolded. Starch absorbs moisture from the gummies during setting.
- Advantages: Well-suited for large-scale production (millions of pieces per day), established equipment ecosystem, predictable results for standard formulations.
- Disadvantages: Starch dust in production workshop must be tightly controlled (explosion risk, employee respiratory protection). Starch requires recycling and drying (energy intensive, cross-contamination risk between batches). Significant capital equipment footprint.
Starch-Free Process (Emerging Standard):
- Method: Gummies are deposited directly into plastic or silicone molds, or extruded and cut without starch. Setting occurs via temperature control or chemical gelation without moisture absorption from starch.
- Advantages: No starch dust eliminates explosion risk and simplifies regulatory compliance (OSHA, ATEX). Enables formulation of heat-sensitive and moisture-sensitive actives (probiotics, Omega-3, vitamin C). Faster changeover between product runs. Lower facility footprint.
- Disadvantages: Higher per-unit tooling cost (custom molds versus generic starch trays). Requires precise process control to achieve consistent shape, texture, and active ingredient distribution.
Industry Transition: While starch molds remain dominant for high-volume, standard vitamin gummies (multivitamin, vitamin C), starch-free processes have become more popular in recent years, particularly for premium and specialty formulations. According to manufacturing equipment supplier data (Q4 2025), 60% of new gummy production lines installed globally in 2024–2025 were starch-free, up from 35% in 2020.
Market Application Segmentation and Growth Drivers
Vitamin and Minerals Gummies (63% Market Share): The anchor segment, driven by daily multivitamin consumption and targeted single-ingredient supplements (vitamin D, vitamin C, calcium with vitamin D). Growth in this segment is transitioning from first-time adoption to brand switching and format upgrades (standard to organic, non-GMO, vegan, sugar-free).
DHA and Omega-3 Gummies (Fastest-Growing Specialty Segment): Driven by prenatal nutrition recommendations (DHA for fetal brain development) and pediatric cognitive health. However, formulation challenges remain significant: Omega-3 oils are prone to oxidation, creating rancid taste and reducing efficacy. Leading manufacturers (PharmaCare, Sirio, Procaps) have developed encapsulation and emulsion technologies that mask fishy taste and extend shelf life to 18+ months.
Probiotics Gummies (Highest Technical Barrier): Probiotic viability requires strict moisture control (water activity below 0.2) and avoidance of high-temperature processing. Starch-free production is essential for this category. Shelf-life stability remains the key differentiator: products guaranteeing potency through expiration date command premium pricing (30–50% above standard gummies).
Plant Extract Gummies (Highest Marketing Differentiation): Elderberry for immunity (surged during and post-pandemic), turmeric for inflammation, ashwagandha for stress, melatonin for sleep. These segments rely heavily on trending ingredients and social media-driven consumer awareness. Brands that secure clinical evidence for their specific gummy formulation (bioavailability studies, efficacy trials) can build durable competitive moats.
Competitive Landscape: Concentrated Market with Top 10 Players at 60%+ Share
The nutraceutical gummies market features a concentrated competitive landscape with significant manufacturing scale advantages. According to QYResearch data, the top 10 suppliers took up more than 60% of the global market.
Key Global and Regional Suppliers:
Church & Dwight (CHD) – US consumer goods giant, brand includes Vitafusion (market leader in US vitamin gummies)
SCN BestCo – US-based, major private label and contract manufacturer
Sirio Pharma – China-based, leading contract manufacturer with global export
Amapharm – European contract manufacturer
Guangdong Yichao – China-based, significant domestic and export volume
Aland – Chinese nutraceutical manufacturer
Herbaland – Canadian gummy specialist, focus on plant-based and sugar-free
Jinjiang Qifeng – Chinese manufacturer
TopGum – Israeli/global contract manufacturer, starch-free specialist
PharmaCare – Australia-based, brand includes Nature’s Way gummies
Hero Nutritionals – US brand (Yummi Bears, early innovator in children’s gummies)
Ningbo Jildan – Chinese manufacturer
Robinson Pharma – US contract manufacturer
Catalent (Bettera Wellness) – Global CDMO, acquired Bettera Wellness for gummy capabilities
UHA – Japanese confectionery and nutraceutical
Ernest Jackson – UK-based (brands including Forceval)
Procaps (Funtrition) – Latin American CDMO with gummy expertise
Cosmax – South Korean CDMO, expanding nutraceutical gummy capacity
MeriCal, Makers Nutrition, NutraLab Corp, Domaco, ParkAcre, Nutra Solutions, VitaWest Nutraceuticals, Themis Medicare (LIN), Jiangsu Handian
Key Success Factors: Scale economics favor large contract manufacturers (Sirio, SCN BestCo, Catalent) that operate multiple high-speed lines, but brand owners (Church & Dwight, PharmaCare, Hero Nutritionals) capture consumer-facing margins. Margins typically range 40–55% at brand level, 15–25% at contract manufacturing level. Switching costs for brand owners are moderate (formulation requalification, packaging changeover, and regulatory notification for label changes), creating stable relationships but not lock-in.
Exclusive Analyst Observation: The Discrete Formulation of Every Gummy
Nutraceutical gummy production sits between discrete manufacturing (each gummy is an individual unit) and batch process manufacturing (ingredients mixed in tanks, deposited continuously). Unlike tablets (which are compressed from powder blends), gummies involve a wet process with significant complexity: active ingredient stability (heat, pH, moisture), texture control (firmness, chewiness, stickiness), sugar or alternative sweetener systems (allulose, stevia, monk fruit), and color/flavor matching. Each new product requires extensive R&D—typically 6–12 months from concept to commercial production—creating a barrier to rapid proliferation. The shift to starch-free processes has accelerated innovation by enabling actives previously incompatible with starch, but also requires new process expertise that not all contract manufacturers possess. Companies that master starch-free production of heat-sensitive and moisture-sensitive actives (probiotics, Omega-3, live botanicals) will capture the highest-value segments of the forecast growth.
Conclusion: Chewable Convenience Meets Functional Formulation
The Nutraceutical Gummies market, at USD 1.55 billion in 2024 projected to reach USD 2.69 billion by 2031 (8.2% CAGR), represents the convergence of consumer preference for palatable formats and the nutraceutical industry’s ability to formulate increasingly complex active ingredients into gummies. For brand owners, the opportunity lies in specialty segments (sleep, immunity, prenatal, probiotics) where clinical evidence and formulation expertise command premium pricing. For contract manufacturers, the battleground is starch-free process capability at scale. For investors, the market offers attractive growth driven by format switching (tablet/capsule to gummy) and demographic expansion (aging populations seeking easier-to-swallow formats, parents preferring gummies for children). The vitamin gummy was the first wave; the second wave—probiotics, Omega-3, plant extracts—is already underway, and the third wave (personalized nutrition, condition-specific formulas) will sustain growth through 2031 and beyond.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
